limb in Biological Technology

Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia

... treat patients with non-reconstructable Critical limb Ischemia (CLI) has completed enrollment . Sri ... University, Chennai, India. Critical limb ischemia is a persistent and relentless problem, ... mortality and morbidity. Prognosis of critical limb ischemia is poor and no effective treatments have ...

Video: Turning Hope Into Reality - VA Research to Restore Veterans' Abilities

... arm that allows those who have lost their limb to perform tasks such as picking up a key, ... on an effort to provide fully integrated limb replacements that enable victims of upper body limb loss to perform arm and hand tasks with the ...

The University of Arizona College of Medicine and OmegaGenesis Announce Collaboration Agreement to Address Diabetic Foot Ulcers

... the director of the University's Southern Arizona limb Salvage Alliance (SALSA). "The problem is ... in the areas of diabetes and prevention of limb amputations resulting from diabetic ulcers. Dr. ... at The University of Arizona's Southern Arizona limb Salvage Alliance," said Oostur Raza, CEO, ...

Touch Bionics unveils innovative partner and reimbursement programs at AOPA

... to support patients with the latest in upper limb technology. "The Partner Program is a key step ... Bionics' clinical advocates, themselves upper limb amputees, in interfacing with new patients and ... to generate interest among existing upper limb patients, new patient contacts from within their ...

New Liko Multiple Purpose Lifting Straps Facilitate Patient Care Tasks

... or problems with holding the patient or limb -- as well as time consuming. When used in ... Typical applications include: -- limb Lifting and Holding -- There are multiple ... units, the Multi-Strap Narrow can suspend a limb with limited skin contact. For the initial ...

Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting

... Mobilization Observed in Subjects with Critical limb Ischemia Treated with ZFP ... most marked clinical improvements, as judged by limb salvage, ulcer healing, reduction in pain and ... 1 clinical trial in subjects (n=20) with critical limb ischemia (Rutherford Grade 4/5). ...

Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology

... knee. As lower extremity PVD worsens, Critical limb Ischemia (CLI) can develop, significantly increasing a patient's risk for amputation and limb loss. An estimated 1.5 - 2 million patients ... which approximately 330,000 patients with lower limb PVD are referred to surgery, either for ...

Sangamo BioSciences Reports Second Quarter 2008 Financial Results

... the trial to test an additional dosing regimen. -- Data from critical limb ischemia Phase 1 trial presented at the International Society for Cellular ... subjects who showed the most marked clinical improvements, as judged by limb salvage, ulcer healing, reduction in pain and increased oxygen ...

Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb

... (LEU) is prevalent throughout the world and poses a major threat to limb integrity. Over 20 percent of all hospital admissions in the US for ... who undergo LEA will ultimately require an amputation of the opposite limb within 5 years. The estimated annual cost of care for treatment of lower ...

Touch Bionics acquires LIVINGSKIN

... CEO. "LIVINGKSIN provides the world's most advanced cosmesis for upper limb prosthetics and the i-LIMB Hand is the world's most advanced upper limb device. It's a perfect match. The acquisition of LIVINGSKIN provides us ...

Vical Licensee AnGes MG Files NDA in Japan for Collategene Angiogenesis Product

... its angiogenesis product candidate, Collategene, for treatment of critical limb ischemia. The treatment uses Vical technology to deliver a gene encoding ... the placebo group subjects. In the trial, 40 subjects with critical limb ischemia (advanced peripheral arterial disease) were evaluated for ...

First Patient Enrolled in SONIC I Registry of OmniSonics Medical Technologies' OmniWave(TM) Endovascular System

... in a number of conditions including deep vein thrombosis (DVT) and acute limb ischemia. DVT affects approximately 2 million people in the U.S. every year, and acute limb ischemia affects over 250,000 people in the U.S. every year. About ...

Touch Bionics adds to sales, marketing, production and design teams

... booth 1117. A workshop presented by Touch Bionics entitled "Bionic Upper limb Technology Made Easy," workshop Number 32, will take place on February 27, ... bionic technology from their practices and transform the lives of upper limb patients. For more information, please visit ...

Touch Bionics expands U.S. presence to meet demand for i-LIMB Hand

... booth 1117. A workshop presented by Touch Bionics entitled "Bionic Upper limb Technology Made Easy," workshop Number 32, will take place on February 27, ... bionic technology from their practices and transform the lives of upper limb patients. For more information, please visit ...

Genzyme and Sunway to Collaborate on Gene Therapy Program in China

... form of peripheral arterial disease that often leads to the need for limb amputation. Genzyme previously completed a Phase 1 study of Ad2/HIF-1a involving patients with critical limb ischemia. A Phase 3 development program would be funded equally by ...

FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels

... deep vein thrombosis (DVT), when large veins are blocked and acute limb ischemia, when there is a sudden decrease of blood flow to the arteries of ... affects approximately 2 million people in the U.S. every year, and acute limb ischemia affects over 250,000 people in the U.S. every year. "Clearly, ...

LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster

... opportunity to capture the significant market share in the bio-surgery area. The Company is changing the standard of care in three initial markets: limb preservation, orthopedics, and shortly in ventral hernia repair. The addition of Pegasus underscores the increasingly diverse nature of our life ...

ULURU to Present Clinical Evidence and Advanced Research on Altrazeal at the Society for Advance Wound Care Conference for 2009

... free mesh skin graft protection. Commenting on the new surgical technique, Dr. James Gleaves, FACS of Rush Hospital Wound Care, Hyperbaric and limb Salvage Center, Meridian, Mississippi and co-author of two posters on the surgical procedure stated, "The development of a technique to cover and ...

AlloSource Distributes Record Amount of Tissue in 2008

... their families) that chose to be tissue donors, whose gifts we processed into allografts that helped people to walk again, live free from pain, avoid limb amputation and survive devastating burns." 2008 accomplishments include: Organic revenue growth of 21 percent as a result of ...

CryoLife, Inc. Receives Tissue From 100,000th Donor, Marking Industry Milestone

... active lifestyle. In addition, cryopreserved allograft vascular tissues have enabled patients with impaired circulatory systems to avoid lower limb amputations. "It has been very gratifying to be able to provide life-saving and life-enhancing tissues to so many patients over the years," ...

TaiGen Biotechnology Secures 37 Million USD in Series C Round Financing

... mobilizer TG-0054, is completing phase 1 trial in the US. TaiGen plans to develop TG-0054 for stem cell transplantation, chemosensitization, critical limb ischemia and age-related macular degeneration. Nemonoxacin, a broad-spectrum non-fluorinated quinolone achieved the non-inferiority clinical cure ...

Health Robotics Announces Results of the European Union-Sponsored SafeChemo Project

... direct costs savings of GBP180,000 per year just from reducing waste with partially used vials. Before CytoCare(TM), RSI [work-related upper limb disorder] affected most of our IV staff. At any given time we had at least one person resting and unable to undertake this type of work, ...

Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601

... randomized to one of two groups. The larger group was treated by intramuscular injection of 60 mg of SB-509 (30 mg of SB-509 per leg) into the lower limb every two months. The remaining group received an equal volume of placebo on the same schedule. Each subject received a total of three treatments ...

Unique New Initiative by World-Recognized Specialists in Heart Disease and Diabetes to Reduce Residual Vascular Risk Launched Today

... - a unique global program to evaluate and reduce the excess risk of myocardial infarction, stroke, kidney disease, loss of vision and non-traumatic limb amputation which exists in many patients with heart disease and diabetes despite optimal, currently available care. The R3i, a worldwide, academic, ...

Media Alert From Residual Risk Reduction Initiative (R3i): 19:00 CST Sunday 9 November 2008

... a unique global program to evaluate and to reduce the excess risk of myocardial infarction, stroke, kidney disease, loss of vision and non-traumatic limb amputation which exists in many patients with heart disease and diabetes despite optimal, currently available care. To address these important ...

Stenum Hospital Does its 600th American Disc Replacement Surgery

... available in the states, thousands of Americans are now heading to Germany, a worldwide technology leader, for breakthrough medical treatments. From limb Transplants too Stem Cell Therapy, Germany is leading the way in the advancement of breakthrough medical procedures. One of these breakthroughs is ...

Scientists restore movement to paralyzed limbs through artificial brain-muscle connections

... to restoring movement through neuroprosthetic devices, one that would link a person's brain to the activation of individual muscles in a paralyzed limb to produce natural control and movements," said Joseph Pancrazio, Ph.D., a program director at the National Institute of Neurological Disorders and ...

Proteon Therapeutics to Present New Data on PRT-201 at Transcatheter Cardiovascular Therapeutics (TCT) Annual Symposium in Washington, D.C., October 13, 2008

... new data today representing an important preclinical demonstration of the potential of PRT-201 to enhance outcomes in patients suffering from lower limb peripheral arterial disease (PAD). The presentation, entitled, "Local Catheter-Directed Elastase Therapy: A Novel Approach to Vessel Dilation and ...

Breakthrough in spinal injury treatment

... had dramatically different effects. One type of astrocyte called GDAsBMP was remarkably effective at promoting nerve regeneration and recovery of limb motion when transplanted into spinal cord injuries. However, the other type of astrocyte cell generated called GDAsCNTF, not only failed to promote ...

US Neuropathic Pain Market Value Doubles to $5 Billion by 2018

... fibromyalgia, diabetic neuropathy, neuropathic cancer pain, complex regional pain syndrome, HIV/AIDS neuropathy, post-herpetic neuralgia, phantom limb pain, spinal cord injury, and trigeminal neuralgia). Insights have also been added from WWMR's US Pain Clinic Monitor -- an audit of more than 100 ...

Limbs saved by menstrual blood stem cells

... Medicine demonstrates that when circulation-blocked mice were treated with ERC injections, circulation and functionality were restored. Critical limb ischemia, an advanced form of peripheral artery disease, causes approximately 150,000 amputations per year in the US. Currently there are no medical ...

Ovalum Ltd. Received Clearance to Market the CiTop™ Product-Line in Israel

... technology greatly assists in rescuing limbs which could not be treated by any other means. Opening an occluded artery is a must for saving the limb from amputation. The CiTop(tm) Guidewire System is crossing these occlusions in tremendous ease even in the most complicated cases". ...

Ovalum Ltd. Announces Sales Launch of CiTop™ Product-Line in Europe

... of chronic complete arterial blockage (CTO). These obstructions are hard to traverse and patients are therefore often referred to bypass surgery or limb amputation. (PRWEB) July 9, 2008 -- Following the approval for CE Marking from the European Economic Area, Ovalum has ...

ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)

... clinical trials already underway, as well as the practice of medicine, evaluating the use of adult stems cells to treat indications such as critical limb ischemia, coronary artery disease and orthopedic conditions. We believe the collection of stem cells from bone marrow could ultimately represent a ...

EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board

... of peripheral vascular disease, hemodialysis access, treatment of carotid and vertebral artery disease to prevent stroke, diabetic foot problems, limb salvage using endovascular techniques and leg bypass surgery, and treatment and prevention of graft stenosis. Dr. Mills has published over 130 ...

Cleveland Clinic and Rutgers to Lead Newly Formed Institute for War Wounded

... of new therapies will focus on the regeneration of bone, muscle, tendon, nerve and blood vessels, as well as new methods for transplantation of limb and facial tissue and the treatment of burns. Cleveland Clinic President and CEO Delos "Toby" Cosgrove has experienced the devastation of war ...

Organogenesis, Inc. to Develop Regenerative Medicine Therapies for U.S. Military Battlefield Injuries

... five years that will focus on the following five areas: -- Burn repair -- Wound healing without scarring -- Craniofacial reconstruction -- limb reconstruction, regeneration or transplantation -- Compartment syndrome, a condition related to inflammation after surgery or injury that can ...

Touch Bionics appoints Head of Clinical Advocacy

... of flexibility and dexterity previously unavailable to the patient, Certified Prosthetist or Occupational Therapist working with upper extremity limb deficiencies. I look forward to being a member of the Touch Bionics team and clinically supporting its revolutionary products to fellow prosthetic ...

Biopure Announces 2008 First Quarter Financial Results

... results from five patients were sufficient to show a trend toward proving the principle being tested. A second safety trial, in patients undergoing limb amputation was also ended in late 2007, primarily because of slow enrollment caused by a protocol design that did not take into account different ...

ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year

... Platform targeted to the processing of bone marrow. Our initial focus will be in the use of bone marrow stem cells in the treatment of critical limb ischemia and myocardial ischemia. We are in the process of preparing a 510 (k) submission and CE Mark application." Separately, the Company ...